Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease

被引:11
作者
Guo, Peng [1 ]
Wang, Rui-dan [1 ]
Lian, Teng-hong [1 ]
Ding, Du-yu [1 ]
Zhang, Ya-nan [2 ]
Zhang, Wei-Jiao [1 ]
Li, Dan-ning [1 ]
Li, Li-xia [3 ]
Li, Jing-hui [1 ]
Guan, Hui-ying [1 ]
Yu, Shu-yang [1 ]
Liu, Li [3 ]
Hu, Yang [1 ]
Zuo, Li-jun [1 ]
Yu, Qiu-jin [1 ]
Wang, Xiao-min [4 ]
Zhang, Wei [5 ,6 ,7 ,8 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Blood Transfus, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Gen Internal Med, Beijing, Peoples R China
[4] Capital Med Univ, Dept Physiol, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Tiantan Hosp, Ctr Cognit Neurol, Dept Neurol, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[7] Beijing Inst Brain Disorders, Ctr Parkinsons Dis, Beijing, Peoples R China
[8] Beijing Key Lab Parkinson Dis, Beijing, Peoples R China
来源
FRONTIERS IN AGING NEUROSCIENCE | 2020年 / 12卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
Parkinson disease; olfactory dysfunction; sniffin' sticks test; cerebrospinal fluid; neuropathologic proteins; ALPHA-SYNUCLEIN; ODOR IDENTIFICATION; NONMOTOR SYMPTOMS; BETA; IMPAIRMENT; TAU; CLEARANCE; PATHOLOGY; BIOMARKER; DEMENTIA;
D O I
10.3389/fnagi.2020.594324
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background and Purpose: Olfactory dysfunction (OD) is a common non-motor symptom of Parkinson disease (PD). However, the relationship between OD and neuropathologic proteins in cerebrospinal fluid (CSF) from PD patients remains unclear. Methods: 166 PD patients were included in the study. Overall olfactory function was assessed by summing up the scores of olfactory threshold, discrimination, and identification by a Sniffin' Sticks test, based on which, patients were divided into PD with OD (PD-OD) and PD with no OD (PD-NOD) groups. CSF samples were obtained from 76 PD patients. The levels of neuropathologic proteins, including alpha-Synuclein, A beta 1-42, total tau (T-tau), and multiple forms of phosphorylated tau (P-tau) in CSF were measured by an enzyme-linked immunosorbent assay. Results: out of the 166 PD patients, 103 cases (62.0%) had OD. The scores of overall olfactory functions, and olfactory threshold, discrimination, and identification in the PD-OD group were all significantly lower than that in the PD-NOD group (P < 0.001). alpha-Synuclein level in CSF was significantly higher in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and negatively correlated with the scores of overall olfactory function, and olfactory discrimination and identification (P < 0.05). A beta 1-42 level in CSF was higher in the PD-OD group than the PD-NOD group, and was significantly and negatively correlated with the olfactory identification score (P < 0.05). T-tau level in CSF was significantly lower in the PD-OD group than the PD-NOD group (P < 0.05), and was significantly and positively correlated with the olfactory discrimination score (P < 0.05). There was no significant difference in P-tau level in CSF between the PD-OD and PD-NOD groups and no correlation between OD score and P-tau level in CSF. Conclusions: PD-OD includes the impairments of olfactory threshold, discrimination, and identification, and is associated with the significant elevation of alpha-Synuclein and the decrease of the T-tau level in CSF.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] Aspects of β-amyloid as a biomarker for Alzheimer's disease
    Andreasson, Ulf
    Portelius, Erik
    Andersson, Malin E.
    Blennow, Kaj
    Zetterberg, Henrik
    [J]. BIOMARKERS IN MEDICINE, 2007, 1 (01) : 59 - 78
  • [2] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [3] Inflammation, Infectious Triggers, and Parkinson's Disease
    Caggiu, Elisa
    Arru, Giannina
    Hosseini, Sepideh
    Niegowska, Magdalena
    Sechi, GianPietro
    Zarbo, Ignazio Roberto
    Sechi, Leonardo A.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [4] Olfaction in Parkinson's disease and related disorders
    Doty, Richard L.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (03) : 527 - 552
  • [5] The expression of α-, β-, and γ-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases
    Duda, JE
    Shah, U
    Arnold, SE
    Lee, VMY
    Trojanowski, JQ
    [J]. EXPERIMENTAL NEUROLOGY, 1999, 160 (02) : 515 - 522
  • [6] Olfactory system pathology as a model of Lewy neurodegenerative disease
    Duda, John E.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) : 49 - 54
  • [7] Neurochemistry and the non-motor aspects of PD
    Ferrer, I.
    Lopez-Gonzalez, I.
    Carmona, M.
    Dalfo, E.
    Pujol, A.
    Martinez, A.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (03) : 508 - 526
  • [8] Three-year prospective study on olfaction of patients with Parkinson's disease
    Fujio, Hisami
    Inokuchi, Go
    Kuroki, Shunsuke
    Tatehara, Shun
    Katsunuma, Sayaka
    Kowa, Hisamoto
    Nibu, Ken-ichi
    [J]. AURIS NASUS LARYNX, 2020, 47 (05) : 899 - 904
  • [9] Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease
    Fullard, Michelle E.
    Morley, James F.
    Duda, John E.
    [J]. NEUROSCIENCE BULLETIN, 2017, 33 (05) : 515 - 525
  • [10] Olfactory impairment predicts cognitive decline in early Parkinson's disease
    Fullard, Michelle E.
    Tran, Baochan
    Xie, Sharon X.
    Toledo, Jon B.
    Scordia, Christi
    Linder, Carly
    Purri, Rachael
    Weintraub, Daniel
    Duda, John E.
    Chahine, Lama M.
    Morley, James F.
    [J]. PARKINSONISM & RELATED DISORDERS, 2016, 25 : 45 - 51